Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the effect of alendronate and lovastatin on socket preservation
IRCT20140318017053N12Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alendronate and lovastatin in Alveolar bone atrophy (ABL) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Socket bone changes. Started Feb 2021; status: completed.
02
Drugs
alendronatelovastatin
03
Conditions
Alveolar bone atrophy (ABL)
Beyond the preview
Go deeper on IRCT20140318017053N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140318017053N12.